{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:45:49Z","timestamp":1760132749951,"version":"build-2065373602"},"reference-count":33,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Mazowieckie Voivodeship local government"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Introduction: Eradication of HCV in the global population remains one of the greatest challenges faced by the WHO. An insufficient level of knowledge and the lack of a national screening test strategy are obstacles to HCV eradication. Aim: This work aimed to summarize surveys assessing risk factors and awareness of the respondents regarding the prevention and course of HCV infection. The summary also includes the most important European and global attempts at eliminating HCV. Materials and Methods: A cross-sectional, population-based study was conducted in the Mazowieckie district in Poland using anonymous surveys and conducted on people who willingly reported for a test. Results: In the study cohort of n = 7397 adults, there were 5412 women (73.16%). The analysis of the quota sample (n = 1303) reflected the actual proportions in the population of the Mazowieckie Voivodeship. Conclusions: Insufficient knowledge about HCV decreases the probability of higher detection of infections, fast diagnostics, and treatment. According to the WHO model, assuming a 90% detection rate and treatment of 80% of infected by 2030, and taking into account 120\u2013150 thousand infected persons in Poland, the number of detections of HCV should be increased 4\u20135 times and all diagnosed persons should be offered antiviral treatment.<\/jats:p>","DOI":"10.3390\/v15102067","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T05:07:13Z","timestamp":1696828033000},"page":"2067","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Global Elimination of HCV\u2014Why Is Poland Still So Far from the Goal?"],"prefix":"10.3390","volume":"15","author":[{"given":"Olga","family":"Tronina","sequence":"first","affiliation":[{"name":"Department of Transplantation Medicine, Nephrology, and Internal Diseases, Medical University of Warsaw, 02-006 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1830-2114","authenticated-orcid":false,"given":"Mariusz","family":"Panczyk","sequence":"additional","affiliation":[{"name":"Department of Education and Research in Health Sciences, Faculty of Health Sciences, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0938-1084","authenticated-orcid":false,"given":"Dorota","family":"Zar\u0119bska-Michaluk","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Allergology, Jan Kochanowski University, 25-317 Kielce, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2717-7741","authenticated-orcid":false,"given":"Joanna","family":"Gotlib","sequence":"additional","affiliation":[{"name":"Department of Education and Research in Health Sciences, Faculty of Health Sciences, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2209-2159","authenticated-orcid":false,"given":"Piotr","family":"Ma\u0142kowski","sequence":"additional","affiliation":[{"name":"Department of Surgical, and Transplantation Nursing, and Extracorporeal Therapies, Medical University of Warsaw, 02-007 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,9]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2023, August 01). Global Health Sector Strategy on Viral Hepatitis 2016\u20132021. Towards Ending Viral Hepatitis. Available online: https:\/\/apps.who.int\/iris\/handle\/10665\/246177."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: Final update of the series","volume":"73","author":"Pawlotsky","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/cid\/ciy585","article-title":"AASLD-IDSA HCV Guidance Panel. Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection","volume":"67","author":"Hepatitis","year":"2018","journal-title":"Clin. Infect Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5114\/ceh.2019.87633","article-title":"Perspectives of hepatitis C virus (HCV) elimination in Poland","volume":"5","author":"Flisiak","year":"2019","journal-title":"Clin. Exp. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/liv.14324","article-title":"Global timing of hepatitis C virus elimination in high-income countries","volume":"40","author":"Razavi","year":"2020","journal-title":"Liver Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/liv.14305","article-title":"Increased cancer rates in patients with chronic hepatitis C","volume":"40","author":"Nyberg","year":"2020","journal-title":"Liver Int."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Tronina, O., Gotlib, J., Ma\u0142kowski, P., Jaworski, M., and Panczyk, M. (2020). Translation and validation study of the Polish version of the Brief Hepatitis C Knowledge Scale. PLoS ONE, 15.","DOI":"10.1037\/t79409-000"},{"key":"ref_8","first-page":"157","article-title":"Hepatitis C in Poland in 2016","volume":"72","author":"Zakrzewska","year":"2018","journal-title":"Przegl. Epidemiol."},{"key":"ref_9","unstructured":"Ndumbi, P., Freidl, G.S., Williams, C.J., Mardh, O., Varela, C., Avell\u00f3n, A., and European Centre for Disease Prevention and Control (2022). Annual Epidemiological Report for 2020, ECDC."},{"key":"ref_10","unstructured":"World Health Organization (2023, September 06). Hepatitis C. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"a036947","DOI":"10.1101\/cshperspect.a036947","article-title":"Challenges and Promise of a Hepatitis C Virus Vaccine","volume":"10","author":"Cox","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jare.2016.11.003","article-title":"Current level of evidence on causal association between hepatitis C virus and type 2 diabetes: A review","volume":"8","author":"Gastaldi","year":"2017","journal-title":"J. Adv. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3389\/fendo.2015.00134","article-title":"Diabetes and Hepatitis C: A Two-Way Association","volume":"6","author":"Hammerstad","year":"2015","journal-title":"Front. Endocrinol."},{"key":"ref_14","unstructured":"World Health Organization (2023, August 01). 2021 Global Progress Report on HIV, Viral Hepatitis and Sexually. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240027077."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"a036939","DOI":"10.1101\/cshperspect.a036939","article-title":"The Elimination of Hepatitis C as a Public Health Threat","volume":"10","author":"Hellard","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1056\/NEJMsr1912628","article-title":"Screening and Treatment Program to Eliminate Hepatitis C in Egypt","volume":"382","author":"Waked","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Suenaga, R., Suka, M., Hirao, T., Hidaka, I., Sakaida, I., and Ishida, H. (2021). Cost-effectiveness of a \u201ctreat-all\u201d strategy using Direct-Acting Antivirals (DAAs) for Japanese patients with chronic hepatitis C genotype 1 at different fibrosis stages. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0248748"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"E167","DOI":"10.9778\/cmajo.20200162","article-title":"Health care costs associated with chronic hepatitis C virus infection in Ontario, Canada: A retrospective cohort study","volume":"9","author":"Wong","year":"2021","journal-title":"CMAJ Open"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1002\/hep.26218","article-title":"Chronic hepatitis C virus (HCV) disease burden and cost in the United States","volume":"57","author":"Razavi","year":"2013","journal-title":"Hepatology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/jvh.12528","article-title":"Association of work productivity with clinical and patient-reported factors in patients infected with hepatitis C virus","volume":"23","author":"Younossi","year":"2016","journal-title":"J. Viral Hepat."},{"key":"ref_21","first-page":"12","article-title":"Eliminacja zaka\u017ce\u0144 wirusem zapalenia w\u0105troby typu C w Europie \u015arodkowej","volume":"20","author":"Flisiak","year":"2020","journal-title":"Hepatologia"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/ceh.2020.93049","article-title":"How close are we to hepatitis C virus elimination in Central Europe?","volume":"6","author":"Flisiak","year":"2020","journal-title":"Clin. Exp. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/hep4.1731","article-title":"Key Elements on the Pathway to HCV Elimination: Lessons Learned from the AASLD HCV Special Interest Group 2020","volume":"5","author":"Feld","year":"2021","journal-title":"Hepatol. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Di Marco, L., La Mantia, C., and Di Marco, V. (2022). Hepatitis C: Standard of Treatment and What to Do for Global Elimination. Viruses, 14.","DOI":"10.3390\/v14030505"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5114\/ceh.2020.94969","article-title":"Searching for the optimal population for hepatitis C virus screening in Poland","volume":"6","author":"Piekarska","year":"2020","journal-title":"Clin. Exp. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/liv.14862","article-title":"Is elimination of HCV realistic by 2030: France","volume":"41","author":"Pol","year":"2021","journal-title":"Liver Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1002\/hsr2.290","article-title":"Hepatitis C virus: Current steps toward elimination in Germany and barriers to reaching the 2030 goal","volume":"4","author":"Sarrazin","year":"2021","journal-title":"Health Sci. Rep."},{"key":"ref_28","unstructured":"Rosi\u0144ska, M., and Zieli\u0144ski, A. (2023, August 01). Raport z Programu Badawczego \u201cOszacowanie Wyst\u0119powania Chor\u00f3b Zaka\u017anych (Wirusowe Zapalenie W\u0105troby Typu C i B, HIV) W\u015br\u00f3d Narkoman\u00f3w Przyjmuj\u0105cych \u015arodki Odurzaj\u0105ce w Iniekcji w Miastach o R\u00f3\u017cnym Stopniu Realizacji Program\u00f3w Redukcji Szk\u00f3d\u201d. Zak\u0142ad Epidemiologii Pa\u0144stwowego Zak\u0142adu Higieny Warszawa, Available online: https:\/\/www.cinn.gov.pl\/."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.18773\/austprescr.2021.003","article-title":"Editorial: Elimination of hepatitis C in Australia by 2030: A decade and counting","volume":"44","author":"Dore","year":"2021","journal-title":"Aust. Prescr."},{"key":"ref_30","unstructured":"Wojtyniak, B., and Gory\u0144ski, P. (2020). Narodowy Instytut Zdrowia Publicznego, Pa\u0144stwowy Zak\u0142ad Higieny."},{"key":"ref_31","unstructured":"(2019). Annual Epidemiological Report for 2017, ECDC. Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/hepatitis-c-annual-epidemiological-report-2017."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/ceh.2023.125957","article-title":"Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2023","volume":"9","author":"Tomasiewicz","year":"2023","journal-title":"Clin. Exp. Hepatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41575-020-0332-6","article-title":"Progress towards elimination goals for viral hepatitis","volume":"17","author":"Cox","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/10\/2067\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:03:19Z","timestamp":1760130199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/10\/2067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,9]]},"references-count":33,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["v15102067"],"URL":"https:\/\/doi.org\/10.3390\/v15102067","relation":{},"ISSN":["1999-4915"],"issn-type":[{"type":"electronic","value":"1999-4915"}],"subject":[],"published":{"date-parts":[[2023,10,9]]}}}